Engineering bacteria in our gut to release medication to treat illnesses automatically is a futuristic concept that could revolutionize the way we administer medicine.
By using genetically modified probiotic bacteria, such as Lactobacillus reuteri, researchers have demonstrated the potential of using bacteria to produce therapeutic molecules and effectively treat rheumatoid arthritis in animal models.
With further research, this method could offer a more convenient and effective way to deliver medications to patients who may not be able to tolerate traditional methods of administering pills or injections.
This could revolutionize treatments for various autoimmune diseases, such as psoriasis, lupus, and multiple sclerosis, by providing an updated approach that could potentially reduce the need for traditional medications over time.
Read the Study > A bioengineered probiotic for the oral delivery of a peptide Kv1.3 channel blocker to treat rheumatoid arthritis
Read more at New Atlas > Bacteria engineered to secrete rheumatoid arthritis drug in the body
